Startseite > Köpfe am DRFZ > Prof. Dr. med. Eicke Latz

Prof. Dr. med. Eicke Latz

Wissenschaftlicher Direktor

Programmbereich 1, PB 1 – Zell- und Gewebe-Rheumatologie

Gruppenleitung: Immunbiologie der Entzündung

Persönliche Assistentin

Tanja Durez

+49 30 28460 601
durez@drfz.de

Biosketch

Prof. Dr. (med.) Eicke Latz studied medicine at the Georg-August University in Göttingen and the Freie Universität Berlin, following which, he worked as an intensive care physician at the Charité Universitätsmedizin. In 2001, he moved to the USA, working as a postdoctoral researcher at Boston University, then at UMass Chan Medical School, where he held his first professorship. In 2010, he returned to Germany and founded the Institute for Innate Immunity at the University Hospital Bonn. He became Scientific Director of the German Rheumatism Research Centre Berlin, a Leibniz Institute, and Professor of Experimental Rheumatology at the Charité Universitätsmedizin Berlin in 2023. His research interests concern how the innate immune system maintains health and under what circumstances it can promote disease. In particular, he investigates the molecular mechanisms that lead to activation or inhibition of the immune system and how these influence the inflammatory reactions in various diseases, such as rheumatic diseases, arteriosclerosis or Alzheimer’s disease.

Prof. Dr. Latz is spokesperson of the Collaborative Research Centre “Metaflammation and Cellular Programming” (SFB 1454) and was previously co-spokesperson of the Cluster of Excellence “ImmunoSensation²”, both at the University of Bonn. He has also co-founded several biotech companies, including IFM Therapeutics (2017), Dioscure Therapeutics (2020), a ‘Stealth’ biotech’ (2020), and Odyssey Therapeutics (2021), which translate his discoveries into novel therapeutics and preventive approaches. He has been a highly cited scientist in immunology since 2014 having published more than 300 publications. Prof. Dr. Latz was elected as a member of the German National Academy of Sciences (Leopoldina) in 2016 and has received a number of prestigious awards, including the Gottfried Wilhelm Leibniz Prize in 2018.

Weblinks:
Google scholar (Eicke Latz)
ORCID (000-0003-1488-5666)
Highly Cited Researcher – 2023 Clarivate™

Scientific Backround

2011 – 2023
Group leader, Innate Immunity in Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

2006 – 2013
Assistant Professor of Medicine, Division of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA

2003 – 2006
Research Assistant Professor of Medicine, Division of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA

2001 – 2003
Postdoctoral Fellow, Division of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA

1999 – 2001
Research Fellow, Molecular Sepsis Research Laboratories, Humboldt-University, Berlin, Germany

1998 – 2001
Internship and Residency (Intensive Care), Department of Surgery, Charité University Hospital, Berlin, Germany

1998
Visiting Scientist, Department of Lipid Biochemistry, Merck Research Laboratories, Rahway, NJ, USA

2001
Doctorate, Medicine (Dr. med.), Free University of Berlin, Berlin, Germany

1998
German Medical Licence Examination (State examination), License to practice Medicine (Approbation), Berlin, Germany

1995 – 2000
US Medical License Examinations I, II, III, Educational Commission for Foreign Medical Graduates, Philadelphia, USA

1991 – 1998
Studies of Medicine, Georg-August-University Göttingen and Free University of Berlin, Berlin, Germany

Since 2024
Chief Innovation Officer, Charité – Universitätsmedizin Berlin, Germany

Since 2024
Member, Innovation Board at Labor Berlin,  Germany.

2023 – date
Portfolio Advisory Board (PAB) Member, IBT Lower Saxony, Germany

2022 – date
ERC Panel Member, ERC starting grants, LS6 – Immunity, Infection and Immunotherapy

2022 – date
Mentor, Creative Destruction Lab (CDL)-Berlin, European School of Management and Technology (ESMT) Berlin, Germany.

2021 – 2023
Elected Member, Supervisory Board of the University of Bonn (‘Hochschulrat’)

2021 – 2023
Speaker, SFB 1454 “Metaflammation and Cellular Programming”, University of Bonn

2018 – 2023
Co-Speaker, Cluster of Excellence “ImmunoSensation2”, University of Bonn

2016 – date
Member, Helmholtz Think Tank, Helmholtz Society, Berlin

2015 – 2023
Chair of Scientific Advisory Board, MPI for Infection Biology, Berlin, Germany

2008 – date
Consultant (current and past): Novartis (Basel, Switzerland); Glaxo Smith Kline (London, UK); Medimmune (Gaithersburg, MD, USA); Biogen (Cambridge, MA, USA); Amgen (Seattle, WA, USA); Eisai Pharmaceuticals (Andover, MA, USA); Altana Pharmaceuticals (Konstanz, Germany); CBio Pharmaceuticals (Brisbane, Australia); Johnson & Johnson (Brussels, Belgium); Boehringer (Ingelheim, Germany)

2008 – 2016
Member of Therapeutic Area Scientific Advisory Panels (TASAP): Inflammation & Immunology, Centers for Therapeutic Innovation, Pfizer (Cambridge, MA, USA)

2010 – 2023
Commissions Head: BONFOR (intramural funding), Research Infrastructure; Commissions Member: Personnel & Strategy, Finance, Core facilities; University of Bonn

2005 – date
Member of Advisory Boards (current and past): Pfizer Worldwide R & D (New York, NY, USA); Grünenthal Pharmaceuticals (Aachen, Germany); Genzyme (Boston, MA, USA); Opsona Pharmaceuticals (Dublin, Ireland)

German Society for Immunology (DGFI), American Association of Immunologists (AAI), International Trained Immunity Consortium (INTRIM), Founding member.

2023
ERC Advanced Research Grant

2018
Gottfried-Wilhelm Leibniz-Prize

2016
Elected Member, German National Academy of Sciences (Leopoldina)

2014-2023
yearly Highly Cited Researcher in Immunology, ‘World’s Most Influential Scientific Minds’ (Thomson Reuters)

2014
Kavli Fellow, United States National Academy of Sciences (NAS)

2014
ERC Consolidator Grant

2011
Glaxo Smith Kline Clinical Science Award

2009
Dana Foundation Award

2004
FOCIS Award

2001
DAAD Postdoctoral Grant

Immunobiologie der Entzündung

Zusammenhänge zwischen angeborener Immunität, chronisch entzündlichen Erkrankungen und gesundem Altern verstehen.